 |
| Dr Haloom Rafehi |
Developing new drugs is an expensive, time-consuming and labour-intensive process.
As costs skyrocket, drug repurposing or repositioning – a process by which existing, clinically approved drugs are repurposed for different conditions – is attracting increasing interest.
A new study by Monash University scientists from the Department of Diabetes investigated the approach and found a group of such drugs that could potentially be used to help counter diabetic complications.
